冠状动脉疾病患者的预后代谢生物标志物的进展 皮肤外冠状动脉干预后的冠状动脉干预
Zi-Teng Zhang1, Jun-Hui Li1, Guo-Qing Qi1
1Heart Center, The First Hospital of Hebei Medical University, 050031 Shijiazhuang, Hebei, China.
识别关键的代谢指标可以帮助预测冠状动脉疾病 (CAD) 的皮肤冠状动脉干预 (PCI) 后的主要不良心血管事件 (MACE). 这些简单的标志物为改善患者的治疗结果和指导临床决策提供了至关重要的见解.
科学领域:
- 心脏病学 心脏病学
- 代谢医学是一种代谢医学.
- 生物标志物发现发现
背景情况:
- 穿皮冠状动脉干预 (PCI) 是冠状动脉疾病 (CAD) 的首要治疗方法,但主要的不良心血管事件 (MACE) 仍然是术后的一个重大问题.
- 早期识别高风险患者和积极的风险因素管理对于改善PCI后的预后至关重要.
研究的目的:
- 审查和综合容易获得的代谢指标,以预测PCI后CAD患者的预后.
- 整合多样化的代谢标记,以准确预测和增强临床决策.
主要方法:
- 文献综述侧重于最近的研究,确定用于PCI后CAD患者预后的代谢生物标志物.
- 预测指标分为四组:血脂,血糖,与营养有关的代谢物和与脏有关的代谢物.
主要成果:
- 简单,可访问的代谢指标证明了CAD患者PCI后预后的早期预测价值.
- 代谢指标的四大关键类别显示出有前途:脂质,葡萄糖,营养和功能标志物.
结论:
- 代谢指标为PCI后CAD患者的预后提供了一种有价值的,实用的方法.
- 进一步整合这些标志物可以加深机理的理解,并支持基于证据的临床策略来降低MACE风险.
更多相关视频
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
